Gelteq Ltd (GELS) stock
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.28+0.01 (+3.93%)
Close on Nov 19, 2026Market cap $3.01MP/E –Yield –
Gelteq net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2024 it was -A$3.55M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | -A$3.55M | – |
| FY2023 | Jun 30, 2023 | -A$3.51M | – |
See a number that looks wrong?